A kind of PVDF wound dressing and preparation method thereof
By constructing an array of silver nanowires and manganese dioxide nanorods and an SOD coating on a PVDF membrane, the problems of oxidative stress and infection in wounds were solved, thereby improving wound oxygenation levels and achieving antibacterial effects, and promoting wound healing.
Patent Information
- Application Number
- CN202310436806.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2023-04-21
- Publication Date
- 2024-11-12
- Estimated Expiration
- 2043-04-21
AI Technical Summary
During wound healing, oxidative stress and infection can cause tissue damage and delayed healing, especially excessive reactive oxygen species and wound hypoxia, which affect the healing effect.
Using a PVDF membrane as the base membrane, silver nanowires and manganese dioxide nanorod arrays were constructed by magnetron sputtering and hydrothermal methods. Combined with a superoxide dismutase (SOD) coating, reactive oxygen species in the wound were converted into oxygen, providing oxygen support and fighting infection.
It effectively eliminates reactive oxygen free radicals in wounds, improves oxygenation levels, promotes cell proliferation and tissue reconstruction in wounds, has antibacterial effects, and significantly accelerates wound healing.
Smart Images

Figure CN116370686B_ABST
Abstract
Description
Technical field:
[0001] The invention belongs to the field of biomedical materials, and specifically relates to a PVDF wound dressing and a preparation method thereof. Background technology:
[0002] Wound healing is a complex and orderly biological process, involving multiple sequential and intersecting pathophysiological processes such as inflammatory response, cell proliferation, migration, and wound remodeling. Cells, extracellular matrix, inflammatory mediators, and various growth factors participate in the wound healing process, and they form a complex wound healing network regulatory relationship through interaction. Any endogenous or exogenous adverse factors that interfere with the wound healing regulatory link can affect the biological process of wound healing, making it impossible for wound healing to be repaired in an orderly manner according to predictable biological steps and phase laws. Oxidative stress is a state of the body in which the homeostasis of pro-oxidants and antioxidants is unbalanced, the production of free radicals increases, and the antioxidant capacity of the body or tissue decreases. Excessive oxidative stress can lead to tissue damage and plays an important role in the development of many diseases. Many cells in the wound microenvironment can produce free radicals such as reactive oxygen species to varying degrees. An appropriate amount of free radicals can play a beneficial role in wound healing, while an excessive amount of free radicals will cause tissue damage and is not conducive to wound healing.
[0003] In addition, wound hypoxia will reduce antibacterial, cell metabolism and growth, and angiogenesis activities. Increased oxygen supply will increase collagen production and wound tension. Due to ruptured blood vessels and high oxygen consumption of metabolically active cells, the microenvironment of the wound is very hypoxic in the early stage. Short-term hypoxia after injury will stimulate wound healing, but long-term or chronic hypoxia will delay wound healing. Especially for infected wounds, the consumption of oxygen by pathogenic bacteria further exacerbates this process, causing the wound to prolong healing. Summary of the invention:
[0004] In view of this, the object of the present invention is to provide a PVDF wound dressing and a preparation method thereof, wherein the PVDF wound dressing can convert harmful active oxygen free radicals into oxygen for release, thereby reducing oxidative stress damage and having anti-infection function, thereby promoting wound healing.
[0005] In order to solve the above technical problems, the present invention provides a PVDF wound dressing and a preparation method thereof, comprising the following steps:
[0006] S1. Using a PVDF membrane as a base membrane, casting a polylactic acid dichloromethane solution on one side of the PVDF membrane, after the solvent is completely volatilized, magnetron sputtering with silver as a target is performed, and then the membrane is placed in a hydrothermal reactor, and an aqueous solution of silver nitrate and polyvinyl pyrrolidone is added, and then an aqueous solution of sodium chloride is slowly added. After the reaction is completed, washing with dichloromethane and drying to obtain a PVDF membrane with silver nanowires on one side;
[0007] S2. Casting the silver nanowire side of the PVDF membrane obtained in step S1 with a dichloromethane solution of polylactic acid into a film, after the solvent is completely volatilized, magnetron sputtering with manganese dioxide as a target is performed, and then the membrane is placed in a hydrothermal reactor, and an aqueous solution of manganese chloride, sodium fluoride and potassium permanganate is added. After the reaction is completed, washing with dichloromethane and drying to obtain a PVDF membrane with silver nanowires / manganese dioxide nanorods on one side;
[0008] S3. The silver nanowire / manganese dioxide nanorod side of the PVDF membrane prepared in step S2 is coated with an aqueous solution of polyvinyl pyrrolidone K30 and SOD to obtain a PVDF membrane having a SOD sandwich structure on one side;
[0009] S4. The SOD sandwich structure surfaces of the two PVDF films having a SOD sandwich structure on one side are bonded and packaged by heat pressing to obtain a PVDF wound dressing.
[0010] Furthermore, the melting point of the polylactic acid is 200-220° C., and the concentration of the dichloromethane solution of the polylactic acid is 100-120 g / L.
[0011] Furthermore, in step S1, the growth conditions of the magnetron sputtering are: RF power 20-50 W, argon pressure 0.1-2 Pa, and growth time 5-10 min.
[0012] Furthermore, in step S1, the amounts of silver nitrate, polyvinyl pyrrolidone and sodium chloride are 100-150 mg / cm 2 Film, 2.64-4.00g / cm 2 Membrane and 100-130mg / cm 2 The membrane, wherein the weight average molecular weight of polyvinyl pyrrolidone is 40000-50000 Da.
[0013] Furthermore, in step S1, the reaction temperature is 140-180° C. and the reaction time is 6-10 h.
[0014] Furthermore, in step S2, the growth conditions of the magnetron sputtering are: RF power 120-140 W, argon pressure 2-3.5 Pa, and growth time 3-5 min.
[0015] Furthermore, in step S2, the dosage of manganese chloride, sodium fluoride and potassium permanganate is 189-320 mg / cm 2 Membrane, 42-126mg / cm 2 Membrane and 158-474mg / cm 2 membrane.
[0016] Furthermore, in step S3, the reaction temperature is 140-180° C. and the reaction time is 24-30 hours.
[0017] Furthermore, in step S3, the dosage of polyvinyl pyrrolidone K30 and SOD is 200-240 mg / cm 2 Membrane and 200-265mg / cm 2 Membrane, in which the enzyme activity of SOD is 30000-50000U / g.
[0018] The present invention also provides a PVDF wound dressing prepared by the above preparation method.
[0019] Compared with the prior art, the present invention has the following technical effects:
[0020] 1) Using PVDF membrane as the base membrane can intercept most of the bacteria, and then using magnetron sputtering and hydrothermal method to construct silver nanowire array and manganese dioxide nanorod array on both sides of the membrane respectively. Silver can play an antibacterial role inside and outside the wound, while manganese dioxide can adsorb SOD and convert the active oxygen free radicals in the wound into non-cytotoxic oxygen through hydrogen peroxide, providing sufficient oxygen for wound cell proliferation and skin tissue reconstruction. In addition, the pore size of PVDF membrane is small, which can prevent SOD from leaking.
[0021] 2) When one side of the PVDF membrane is treated using high melting point polylactic acid as a sealant, the structure and activity of the other side can be retained. After the treatment, it can be dissolved and washed away with dichloromethane. Description of the drawings:
[0022] Figure 1 This is a schematic diagram of the structure of the PVDF wound dressing prepared by the present invention. Specific implementation method:
[0023] In order to further understand the present invention, preferred embodiments of the present invention are described below in conjunction with examples, but it should be understood that these descriptions are only for further illustrating the features and advantages of the present invention, rather than limiting the claims of the present invention.
[0024] Example 1
[0025] A PVDF wound dressing and a preparation method thereof, comprising the following steps:
[0026] 1. One side of the PVDF membrane was cast into a film with a 108 g / L dichloromethane solution of polylactic acid with a melting point of 205°C. After the solvent was completely volatilized, magnetron sputtering I was performed. The target material was silver. The growth conditions were: RF power 22W, argon pressure 0.7Pa, growth time 7min. Then the membrane was placed in a hydrothermal reactor, silver nitrate and polyvinyl pyrrolidone aqueous solution were added, and then sodium chloride aqueous solution was slowly added. The amount of silver nitrate, polyvinyl pyrrolidone with a weight average molecular weight of 44000Da, and sodium chloride was 110 mg / cm 2 Film, 2.80g / cm 2 Film and 120mg / cm 2 The membrane was reacted at 160 °C for 8 h, washed with dichloromethane, and dried to obtain a PVDF membrane with silver nanowires on one side;
[0027] 2. The silver nanowire side of the silver nanowire PVDF membrane prepared in step 1 was cast into a film with a 110 g / L dichloromethane solution of polylactic acid with a melting point of 215°C. After the solvent was completely volatilized, magnetron sputtering II was performed. The target material was manganese dioxide. The growth conditions were: RF power 130 W, argon pressure 2.5 Pa, and growth time 4 min. Then, the membrane was placed in a hydrothermal reactor and an aqueous solution of manganese chloride, sodium fluoride, and potassium permanganate was added. The amount of manganese chloride, sodium fluoride, and potassium permanganate was 200 mg / cm 2 Membrane, 86mg / cm 2 Membrane and 254mg / cm 2 The membrane was reacted at 165 °C for 26 h, washed with dichloromethane, and dried to obtain a PVDF membrane with silver nanowires / manganese dioxide nanorods on one side;
[0028] 3. The manganese dioxide nanorod side of the silver nanowire / manganese dioxide nanorod PVDF membrane prepared in step 2 was coated with an aqueous solution of polyvinyl pyrrolidone K30 and SOD with an enzyme activity of 48000 U / g, and the amount of polyvinyl pyrrolidone K30 and SOD was 215 mg / cm 2 Film and 260mg / cm 2 Membrane, to obtain a PVDF membrane with a SOD sandwich structure on one side;
[0029] 4. Prepare another PVDF membrane with a SOD sandwich structure, and then heat-press and bond two PVDF membranes with SOD sandwich structures with one side of the SOD sandwich structure facing each other to obtain a PVDF wound dressing.
[0030] Example 2
[0031] A PVDF wound dressing and a preparation method thereof, comprising the following steps:
[0032] 1. One side of the PVDF membrane was cast into a film with a 100 g / L dichloromethane solution of polylactic acid with a melting point of 220°C. After the solvent was completely volatilized, magnetron sputtering I was performed. The target material was silver. The growth conditions were: RF power 50 W, argon pressure 0.1 Pa, growth time 10 min. Then the membrane was placed in a hydrothermal reactor, silver nitrate and polyvinyl pyrrolidone aqueous solution were added, and then sodium chloride aqueous solution was slowly added. The amount of silver nitrate, polyvinyl pyrrolidone with a weight average molecular weight of 40000 Da, and sodium chloride was 100 mg / cm 2 Film, 4.00g / cm 2 Film and 130mg / cm 2 The membrane was reacted at 140 °C for 10 h, washed with dichloromethane, and dried to obtain a PVDF membrane with silver nanowires on one side;
[0033] 2. The silver nanowire side of the silver nanowire PVDF membrane prepared in step 1 was cast into a film with a 100 g / L dichloromethane solution of polylactic acid with a melting point of 200°C. After the solvent was completely volatilized, magnetron sputtering II was performed. The target material was manganese dioxide. The growth conditions were: RF power of 140 W, argon pressure of 2 Pa, and growth time of 5 min. Then, the membrane was placed in a hydrothermal reactor and an aqueous solution of manganese chloride, sodium fluoride and potassium permanganate was added. The amount of manganese chloride, sodium fluoride and potassium permanganate was 320 mg / cm 2 Membrane, 42mg / cm 2 Membrane and 474mg / cm 2 The membrane was reacted at 140 °C for 30 h, washed with dichloromethane, and dried to obtain a PVDF membrane with silver nanowires / manganese dioxide nanorods on one side;
[0034] 3. The manganese dioxide nanorod side of the silver nanowire / manganese dioxide nanorod PVDF membrane prepared in step 2 was coated with an aqueous solution of polyvinyl pyrrolidone K30 and SOD with an enzyme activity of 30,000 U / g, and the amount of polyvinyl pyrrolidone K30 and SOD was 200 mg / cm 2 Membrane and 265mg / cm 2 Membrane, to obtain a PVDF membrane with a SOD sandwich structure on one side;
[0035] 4. Prepare another PVDF membrane with a SOD sandwich structure, and then heat-press and bond two PVDF membranes with SOD sandwich structures with one side of the SOD sandwich structure facing each other to obtain a PVDF wound dressing.
[0036] Example 3
[0037] A PVDF wound dressing and a preparation method thereof, comprising the following steps:
[0038] 1. One side of the PVDF membrane was cast into a film with a 120 g / L dichloromethane solution of polylactic acid with a melting point of 200°C. After the solvent was completely volatilized, magnetron sputtering I was performed. The target material was silver. The growth conditions were: RF power of 20 W, argon pressure of 2 Pa, and growth time of 5 min. Then, the membrane was placed in a hydrothermal reactor, and silver nitrate and polyvinyl pyrrolidone aqueous solution were added. Then, sodium chloride aqueous solution was slowly added. The amount of silver nitrate, polyvinyl pyrrolidone with a weight average molecular weight of 50,000 Da, and sodium chloride was 150 mg / cm 2 Film, 2.64g / cm 2 Film and 100mg / cm 2 The membrane was reacted at 180 °C for 6 h, washed with dichloromethane, and dried to obtain a PVDF membrane with silver nanowires on one side;
[0039] 2. The silver nanowire side of the silver nanowire PVDF membrane prepared in step 1 was cast into a film with a 120 g / L dichloromethane solution of polylactic acid with a melting point of 220°C. After the solvent was completely volatilized, magnetron sputtering II was performed. The target material was manganese dioxide. The growth conditions were: RF power of 120 W, argon pressure of 3.5 Pa, and growth time of 3 min. Then, the membrane was placed in a hydrothermal reactor and an aqueous solution of manganese chloride, sodium fluoride and potassium permanganate was added. The amount of manganese chloride, sodium fluoride and potassium permanganate was 189 mg / cm 2 Membrane, 126mg / cm 2 Membrane and 158mg / cm 2 The membrane was reacted at 180 °C for 24 h, washed with dichloromethane, and dried to obtain a PVDF membrane with silver nanowires / manganese dioxide nanorods on one side;
[0040] 3. The manganese dioxide nanorod side of the silver nanowire / manganese dioxide nanorod PVDF membrane prepared in step 2 was coated with an aqueous solution of polyvinyl pyrrolidone K30 and SOD with an enzyme activity of 50,000 U / g, and the amount of polyvinyl pyrrolidone K30 and SOD was 240 mg / cm 2 Film and 200mg / cm 2 Membrane, to obtain a PVDF membrane with a SOD sandwich structure on one side;
[0041] 4. Prepare another PVDF membrane with a SOD sandwich structure, and then heat-press and bond two PVDF membranes with SOD sandwich structures with one side of the SOD sandwich structure facing each other to obtain a PVDF wound dressing.
[0042] Comparative Example 1 (without manganese dioxide)
[0043] A PVDF wound dressing and a preparation method thereof, comprising the following steps:
[0044] 1. One side of the PVDF membrane was cast into a film with a 108 g / L dichloromethane solution of polylactic acid with a melting point of 205°C. After the solvent was completely volatilized, magnetron sputtering I was performed. The target material was silver. The growth conditions were: RF power 22W, argon pressure 0.7Pa, growth time 7min. Then the membrane was placed in a hydrothermal reactor, silver nitrate and polyvinyl pyrrolidone aqueous solution were added, and then sodium chloride aqueous solution was slowly added. The amount of silver nitrate, polyvinyl pyrrolidone with a weight average molecular weight of 44000Da, and sodium chloride was 110 mg / cm 2 Film, 2.80g / cm 2 Film and 120mg / cm 2 The membrane was reacted at 160 °C for 8 h, washed with dichloromethane, and dried to obtain a silver nanowire PVDF membrane;
[0045] 2. The silver nanowire side of the silver nanowire PVDF membrane prepared in step 1 was coated with an aqueous solution of polyvinyl pyrrolidone K30 and SOD with an enzyme activity of 48000 U / g, and the amount of polyvinyl pyrrolidone K30 and SOD was 215 mg / cm 2 Film and 260mg / cm 2 The film is then heat-pressed and bonded with the coated surfaces of the two films to obtain a PVDF wound dressing.
[0046] Comparative Example 2 (without silver nanowires)
[0047] A PVDF wound dressing and a preparation method thereof, comprising the following steps:
[0048] 1. One side of the PVDF membrane was cast into a film with a 110 g / L dichloromethane solution of polylactic acid with a melting point of 215°C. After the solvent was completely evaporated, magnetron sputtering II was performed. The target material was manganese dioxide. The growth conditions were: RF power 130 W, argon pressure 2.5 Pa, and growth time 4 min. Then the membrane was placed in a hydrothermal reactor and an aqueous solution of manganese chloride, sodium fluoride, and potassium permanganate was added. The dosage of manganese chloride, sodium fluoride, and potassium permanganate was 200 mg / cm 2 Membrane, 86mg / cm 2 Membrane and 254mg / cm 2 The membrane was reacted at 165 °C for 26 h, washed with dichloromethane, and dried to obtain a manganese dioxide nanorod PVDF membrane;
[0049] 2. The opposite side of the manganese dioxide nanorods of the manganese dioxide nanorod PVDF membrane prepared in step 1 is coated with an aqueous solution of polyvinyl pyrrolidone K30 and SOD with an enzyme activity of 48000 U / g, and the amount of polyvinyl pyrrolidone K30 and SOD is 215 mg / cm 2 Film and 260mg / cm 2The film is then heat-pressed and bonded with the coated surfaces of the two films to obtain a PVDF wound dressing.
[0050] Comparative Example 3 (without SOD coating)
[0051] A PVDF wound dressing and a preparation method thereof, comprising the following steps:
[0052] 1. One side of the PVDF membrane was cast into a film with a 108 g / L dichloromethane solution of polylactic acid with a melting point of 205°C. After the solvent was completely volatilized, magnetron sputtering I was performed. The target material was silver. The growth conditions were: RF power 22W, argon pressure 0.7Pa, growth time 7min. Then the membrane was placed in a hydrothermal reactor, silver nitrate and polyvinyl pyrrolidone aqueous solution were added, and then sodium chloride aqueous solution was slowly added. The amount of silver nitrate, polyvinyl pyrrolidone with a weight average molecular weight of 44000Da, and sodium chloride was 110 mg / cm 2 Film, 2.80g / cm 2 Film and 120mg / cm 2 The membrane was reacted at 160 °C for 8 h, washed with dichloromethane, and dried to obtain a silver nanowire PVDF membrane;
[0053] 2. The silver nanowire side of the silver nanowire PVDF membrane prepared in step 1 was cast into a film with a 110 g / L dichloromethane solution of polylactic acid with a melting point of 215°C. After the solvent was completely volatilized, magnetron sputtering II was performed. The target material was manganese dioxide. The growth conditions were: RF power 130 W, argon pressure 2.5 Pa, and growth time 4 min. Then, the membrane was placed in a hydrothermal reactor and an aqueous solution of manganese chloride, sodium fluoride, and potassium permanganate was added. The amount of manganese chloride, sodium fluoride, and potassium permanganate was 200 mg / cm 2 Membrane, 86mg / cm 2 Membrane and 254mg / cm 2 The membrane was reacted at 165 °C for 26 h, washed with dichloromethane, and dried to obtain the silver nanowire / manganese dioxide nanorod PVDF membrane;
[0054] 3. The manganese dioxide nanorod surfaces of the silver nanowire / manganese dioxide nanorod PVDF membrane prepared in step 2 are bonded and packaged by heat pressing to obtain a PVDF wound dressing.
[0055] Infected wound healing experiment
[0056] Six-month-old SPF male Yorkshire pigs were selected and anesthetized. After hair removal on the back, the wound was disinfected with iodine and a circular full-thickness wound with a diameter of about 2 cm was excised with a punch. 6The wound was infused with a Staphylococcus aureus solution of 1.5 cfu / ml, and then treated with the PVDF wound dressings prepared in Examples 1-3 and Comparative Examples 1-3, respectively. The dressings were changed every 2 days and fixed with medical tape. The healing time was recorded. The results are shown in Table 1.
[0057] Table 1
[0058]
[0059] As can be seen from Table 1, the wounds treated with the PVDF wound dressings of Examples 1-3 healed the fastest, while the healing rates of the PVDF wound dressings of Comparative Examples 1-3 were significantly lower than those prepared in the Examples. This is mainly because the PVDF wound dressings prepared by the present invention can remove free radicals, improve the oxygenation level of the wound, and have obvious antibacterial and antibacterial effects, which ultimately accelerates wound healing.
[0060] Oxygen free radical scavenging and oxygen production experiments
[0061] The PVDF wound dressings prepared in Examples 1-3 and Comparative Examples 1-3 were used to perform irradiation riboflavin reaction, and the O2 generated by the irradiation riboflavin system was detected. ·- The removal rate was determined by oxygen electrode, and the results are shown in Table 2.
[0062] Table 2
[0063] Example 1 Example 2 Example 3 Comparative Example 1 Comparative Example 2 Comparative Example 3 <![CDATA[O2 ·- Clearance rate (%)]]> 100.0±0.00 97.48±1.47 97.23±0.92 85.74±1.35 96.54±1.03 7.68±1.66 Dissolved oxygen (mg / L) 6.26±0.01 6.08±0.02 6.20±0.02 0.44±0.03 6.13±0.02 0.29±0.01
[0064] As can be seen from Table 2, the PVDF wound dressings of Examples 1-3 can effectively remove active oxygen free radicals and release enough oxygen to saturate the liquid with dissolved oxygen. However, the PVDF wound dressing of Comparative Example 1 has a weak ability to remove free radicals, mainly because there is no manganese dioxide as a catalyst, and the hydrogen peroxide produced by the SOD reaction accumulates and cannot be quickly decomposed into oxygen and water, inhibiting the removal of free radicals. The PVDF wound dressing of Comparative Example 3 lacks SOD and cannot remove free radicals, and then cannot generate oxygen.
[0065] The present invention provides a PVDF wound dressing and a method for preparing the same. There are many methods and approaches to implement the technical solution. The above is only a preferred embodiment of the present invention. It should be pointed out that for ordinary technicians in this technical field, several improvements and modifications can be made without departing from the principle of the present invention. These improvements and modifications should also be regarded as the protection scope of the present invention. All components not specified in this embodiment can be implemented by existing technologies.
Claims
1. A method for preparing a PVDF wound dressing, characterized in that: The steps include: S1. Using a PVDF membrane as a base membrane, casting a polylactic acid dichloromethane solution on one side of the PVDF membrane, after the solvent is completely volatilized, magnetron sputtering with silver as a target is performed, and then the membrane is placed in a hydrothermal reactor, and an aqueous solution of silver nitrate and polyvinyl pyrrolidone is added, and then an aqueous solution of sodium chloride is slowly added. After the reaction is completed, washing with dichloromethane and drying to obtain a PVDF membrane with silver nanowires on one side; S2. Casting the silver nanowire side of the PVDF membrane obtained in step S1 with a dichloromethane solution of polylactic acid into a film, after the solvent is completely volatilized, magnetron sputtering with manganese dioxide as a target is performed, and then the membrane is placed in a hydrothermal reactor, and an aqueous solution of manganese chloride, sodium fluoride and potassium permanganate is added. After the reaction is completed, washing with dichloromethane and drying to obtain a PVDF membrane with silver nanowires / manganese dioxide nanorods on one side; S3. The manganese dioxide nanorods on one side of the PVDF membrane prepared in step S2 are coated with an aqueous solution of polyvinyl pyrrolidone K30 and SOD to obtain a PVDF membrane having a SOD sandwich structure on one side; S4. The SOD sandwich structure surfaces of the two PVDF films having a SOD sandwich structure on one side are bonded and packaged by heat pressing to obtain a PVDF wound dressing.
2. The preparation method according to claim 1, characterized in that: The melting point of the polylactic acid is 200-220° C., and the concentration of the dichloromethane solution of the polylactic acid is 100-120 g / L.
3. The preparation method according to claim 1, characterized in that: In step S1, the growth conditions of the magnetron sputtering are: RF power 20-50 W, argon pressure 0.1-2 Pa, and growth time 5-10 min.
4. The preparation method according to claim 1, characterized in that: In step S1, the amounts of silver nitrate, polyvinyl pyrrolidone and sodium chloride are 100-150 mg / cm 2 Film, 2.64-4.00g / cm 2 Membrane and 100-130mg / cm 2 The membrane, wherein the weight average molecular weight of polyvinyl pyrrolidone is 40000-50000 Da.
5. The preparation method according to claim 1, characterized in that: In step S1, the reaction temperature is 140-180°C and the reaction time is 6-10 hours.
6. The preparation method according to claim 1, characterized in that: In step S2, the growth conditions of the magnetron sputtering are: RF power 120-140 W, argon pressure 2-3.5 Pa, and growth time 3-5 min.
7. The preparation method according to claim 1, characterized in that: In step S2, the dosage of manganese chloride, sodium fluoride and potassium permanganate is 189-320 mg / cm 2 Membrane, 42-126mg / cm 2 Membrane and 158-474mg / cm 2 membrane.
8. The preparation method according to claim 1, characterized in that: In step S3, the reaction temperature is 140-180° C. and the reaction time is 24-30 hours.
9. The preparation method according to claim 1, characterized in that: In step S3, the dosage of polyvinyl pyrrolidone K30 and SOD is 200-240 mg / cm 2 Membrane and 200-265mg / cm 2 Membrane, in which the enzyme activity of SOD is 30000-50000U / g.
10. The PVDF wound dressing prepared according to the preparation method according to any one of claims 1 to 9.
Citation Information
Patent Citations
Medicinal silver-loaded metal bioactive coating as well as preparation method and application thereof
CN102886071A
Preparation method of antibacterial hydrophobic ZnO nanorod
CN106756898A
Gold nanocage-manganese dioxide composite nanoparticle as well as preparation method and application thereof
CN107670040A
Silver nanowire and its preparation method, silver nanowire film and laminated film
CN108971510A
Calcium-mingled tantalum oxide nanometer bar structure biological activity coating and preparation method thereof
CN109722660A
